This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of South Florida. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Innovations by Basil Cherpelis in Neurodegenerative Disease Treatment
Introduction
Basil Cherpelis is an innovative inventor based in Tampa, FL (US). He has made significant contributions to the field of neuroscience, particularly in the treatment of neurodegenerative diseases such as Alzheimer's disease. His work focuses on the conversion of non-neuronal cells into neurons, which has the potential to revolutionize therapeutic approaches for these conditions.
Latest Patents
Basil Cherpelis holds a patent for the "Conversion of non-neuronal cells into neurons." This invention encompasses materials and methods for converting non-neuronal cells into functional neurons. Additionally, it includes methods for screening drugs and other compounds for their efficacy in treating Alzheimer's disease using the neuronal cells produced through this invention. The patent also covers methods for evaluating therapeutic treatments for efficacy in individuals or animals suffering from Alzheimer's disease or other neurodegenerative conditions.
Career Highlights
Cherpelis is affiliated with the University of South Florida, where he conducts research and develops innovative solutions for neurodegenerative diseases. His work has garnered attention for its potential impact on treatment methodologies and patient care.
Collaborations
Some of his notable coworkers include Siddharth G Kamath and Chad Dickey, who contribute to the collaborative research efforts at the University of South Florida.
Conclusion
Basil Cherpelis is a prominent inventor whose work in converting non-neuronal cells into neurons holds promise for advancing treatments for Alzheimer's disease and other neurodegenerative conditions. His contributions to neuroscience are paving the way for innovative therapeutic strategies that could significantly improve patient outcomes.